IGF-1 DES vs hBD-1
Head-to-head comparison of IGF-1 DES (Des(1-3) Insulin-like Growth Factor 1) and hBD-1 (Human beta-defensin 1) — benefits, dosing, side effects, research data, and where to buy.
| Property | IGF-1 DES | hBD-1 |
|---|---|---|
| Category | Growth Hormone | Dental & Oral |
| Full Name | Des(1-3) Insulin-like Growth Factor 1 | Human beta-defensin 1 |
| Molecular Weight | 7365 Da | 4490 Da |
| Half-Life | ~20-30 minutes | minutes to hours |
| Amino Acids | 67 | 36 |
| Typical Dose | — | 1-10 µg/mL in experimental studies |
| Route | — | Topical/Intraoral |
| Purity | >98% | ≥98% |
| Studies Count | 65 | 85 |
| Research Status | Active Research | Pre-clinical |
IGF-1 DES Benefits
- ✓Highly potent localized muscle growth, enhanced protein synthesis, satellite cell proliferation, does not bind to IGFBPs, rapid onset
hBD-1 Benefits
- ✓oral innate immunity
- ✓broad antimicrobial activity
- ✓biofilm suppression
- ✓periodontal support
IGF-1 DES Dosing
50-150 mcg per injection site bilaterally post-workout. 4-6 week cycles due to potency. Multiple daily injections in research.
hBD-1 Dosing
topical peptide exposure|cell-culture or mucosal models|repeat low-dose application in research
IGF-1 DES Side Effects
- ⚠Hypoglycemia (dose-dependent), localized swelling, shorter duration limits systemic exposure compared to IGF-1 LR3.
hBD-1 Side Effects
- ⚠protease degradation
- ⚠local irritation at high dose
- ⚠limited stability in saliva
Research Overview
IGF-1 DES
Missing first three amino acids (Gly-Pro-Glu) eliminates IGFBP binding, resulting in 100% bioavailable IGF-1R stimulation. Activates PI3K/Akt/mTOR for protein synthesis and satellite cell proliferation.
hBD-1
hBD-1 has been studied as part of the oral mucosal defense system and is linked to host resistance against dental pathogens. Research spans periodontitis, candidiasis, and epithelial barrier biology.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.